[2] Mundo Sano was originally established to combat against Chagas disease that is prevalent in Latin America, and was transmitted to other parts of the world from there.

[7] Mundo Sano Foundation was founded in 1993 by Dr Roberto Gold with the aim of improving of the quality of life in Argentina, where human helminthic diseases were rampant.

It forms many partnerships such as with the Global Network for Neglected Tropical Diseases to fight Strongyloides stercoralis infections and other soil-transmitted helminths (STH) in Argentina.

Mundo Sano specifically contributed US$5 million for project expansion and program enhancement for selected sites in the Americas and Africa.

Mundo Sano and the Chemo Pharmaceutical Group developed a second generic version of benznidazole, which is manufactured by the Argentine company Laboratorio ELEA under the name Abarax.